Scott Alexander examines the surprisingly broad effects of GLP-1 drugs like Ozempic, exploring their mechanisms and speculating on why they seem to impact so many different conditions. Longer summary

Scott Alexander explores the wide-ranging effects of GLP-1 receptor agonist medications like Ozempic, which are approved for diabetes and obesity but show promise for many other conditions. He delves into the mechanisms behind their effects on diabetes, weight loss, and addiction, speculating on why these drugs seem to have such broad impacts. The post discusses how GLP-1 drugs work in the brain to reduce hunger and dampen reward systems, potentially explaining their effects on addiction. Scott also touches on their anti-inflammatory properties and potential benefits for neurodegenerative diseases, while cautioning that some reported effects may not replicate. Shorter summary

Scott Alexander presents a roundup of recent scientific and medical studies, covering topics from hallucinations to obesity genetics to schizophrenia treatment. Longer summary

This post is a collection of various scientific and medical studies and news. It covers a range of topics including hallucinations, diet and longevity, gene-environment interactions in psychiatry, life-extending drugs, fibromyalgia, chemical education, drug company tactics, sleep theories, psychotherapy effectiveness, obesity genetics, and schizophrenia treatment. Scott provides brief summaries and commentary on each item, often with a mix of scientific insight and humor. Shorter summary